P Christian Schulze
P Christian Schulze is an expert in Cardiology at Jena University Hospital (Germany). As of October 2026, ScienceLeadR ranks P Christian Schulze in the top 1% of experts worldwide for Heart Failure, Cardiomyopathies and Myocardial Ischemia. P Christian Schulze has authored 685 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 7 of them ongoing. SLR score: 2,862 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biochemistry - Biostatistics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 685
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| New insights into takotsubo syndrome: results from a multicenter cohort. PMID 42895542 — heart diseases, emergencies, stress, physiological, brain, recycling, takotsubo cardiomyopathy | Clin Res Cardiol | 2026 | 0 |
| Complexity of coronary artery disease in infarct-related cardiogenic shock and multivessel disease: a substudy of the DanGer Shock trial. PMID 42837204 — mortality, coronary artery disease, shock, cardiogenic, arteries, cardiac surgical procedures | EuroIntervention | 2026 | 1 |
| Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network. PMID 42803952 — heart diseases, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors | Clin Res Cardiol | 2026 | 0 |
| Predicting LDL-cholesterol reduction variability on statin-ezetimibe therapy: insights from "Jena auf Ziel". PMID 42690415 — ezetimibe, cholesterol, ldl, myocardial infarction, st elevation myocardial infarction, cholesterol, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, atorvastatin, absorption | Herz | 2026 | 0 |
| Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation. PMID 42670987 — constriction, pathologic, aortic valve stenosis, coronary artery disease, arteries, aortic valve, transcatheter aortic valve replacement, random allocation | N Engl J Med Top journal | 2026 | 4 |
Clinical Studies 29
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
7 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| 202301CPC Redefine HF 2023-508581-15-00 — mortality, safety, heart failure, heart, morbidity | Phase 3 | Recruiting | 2024 |
| A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure 2023-509706-30-00 — safety, heart failure, heart | Phase 3 | Recruiting | 2024 |
| Mitral Valve Edge to Edge Repair in Patients With Exercise Induced Severe Mitral Regurgitation NCT07709208 — exercise, sodium-glucose transporter 2 inhibitors, angiotensin-converting enzyme inhibitors, mitral valve, heart failure, heart, signs and symptoms, receptors, mineralocorticoid, physicians, diuretics, therapeutics, mineralocorticoids, mineralocorticoid receptor antagonists, mitral valve insufficiency | N/A | Recruiting | 2026 |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non Obstructive Hypertrophic Cardiomyopathy (nHCM) NCT06081894 — safety, multiple chronic conditions, tablets, cardiomyopathy, hypertrophic, cardiomyopathies | Phase 3 | Active not recruiting | 2023 |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI NCT05786131 — myocardial ischemia, coronary artery disease, myocardial infarction, percutaneous coronary intervention, arteries, st elevation myocardial infarction, coronary disease, non-st elevated myocardial infarction, wounds and injuries, ischemia | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map